SciRhom Revenue and Competitors
Estimated Revenue & Valuation
- SciRhom's estimated annual revenue is currently $3.3M per year.
- SciRhom's estimated revenue per employee is $155,000
- SciRhom's total funding is $86M.
Employee Data
- SciRhom has 21 Employees.
- SciRhom grew their employee count by 62% last year.
SciRhom's People
| Name | Title | Email/Phone |
|---|
SciRhom Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | 18% | N/A | N/A |
#2 | $46.7M | 301 | 26% | N/A | N/A |
#3 | $38.9M | 251 | 11% | N/A | N/A |
#4 | $3.3M | 21 | 62% | $85.6M | N/A |
#5 | $17.5M | 113 | N/A | N/A | N/A |
#6 | $2.6M | 17 | 31% | $45.3M | N/A |
#7 | $23.1M | 122 | 4% | $9.6M | N/A |
What Is SciRhom?
SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A
$86M
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
62%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Martinsried
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.6M | 44 | 38% | N/A |
#2 | $10.5M | 68 | 13% | $271M |
#3 | $9.1M | 72 | 36% | N/A |
#4 | $41M | 152 | 25% | N/A |